Skin microbiota-host interactions

Nature

Volumn 553, Issue 7689, 2018, Pages 427-436

  Erin Chen, Y ^a,b   Fischbach, Michael A ^b   Belkaid, Yasmine ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Stanford University   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM; FUNGUS; HOST-PARASITE INTERACTION; IMMUNITY; MICROORGANISM; PATHOGENICITY; PHYSIOLOGY; SKIN; VIRUS;

ACNE; ANTIBODY RESPONSE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIAL SKIN DISEASE; BACTERIAL VIRULENCE; COMMENSAL; COMMENSALISM; CORYNEBACTERIUM; GENETIC PREDISPOSITION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNOMODULATION; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SKIN FLORA; STAPHYLOCOCCUS; STRAIN DIFFERENCE; SYMBIOSIS; WOUND HEALING; ANIMAL; CHEMISTRY; GENETICS; HEALTH; IMMUNOLOGY; MICROBIOLOGY; MICROFLORA; ORGANISMAL INTERACTION; PHYSIOLOGY; SKIN;

FUNGI;

ANIMALS; HEALTH; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROBIAL INTERACTIONS; MICROBIOTA; SKIN; SYMBIOSIS;

EID: 85041136725     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature25177     Document Type: Review

References (161)

1. De Luca, C. & Valacchi, G. Surface lipids as multifunctional mediators of skin responses to environmental stimuli. Mediators Inflamm. 2010, 321494 (2010).
2. van Smeden, J. & Bouwstra, J. A. Stratum corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients. Curr. Probl. Dermatol. 49, 8-26 (2016).
3. Niyonsaba, F., Kiatsurayanon, C., Chieosilapatham, P. & Ogawa, H. Friends or foes? Host defense (antimicrobial) peptides and proteins in human skin diseases. Exp. Dermatol. 26, 989-998 (2017).
4. Bek-Thomsen, M., Lomholt, H. B., Scavenius, C., Enghild, J. J. & Brggemann, H. Proteome analysis of human sebaceous follicle infundibula extracted from healthy and acne-affected skin. PLoS One 9, e107908 (2014).
5. Lee, D.-Y. et al. Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill propionibacterium acnes. J. Invest. Dermatol. 128, 1863-1866 (2008).
6. Boncheva, M. The physical chemistry of the stratum corneum lipids. Int. J. Cosmet. Sci. 36, 505-515 (2014).
7. Matard, B. et al. First evidence of bacterial biofilms in the anaerobe part of scalp hair follicles: a pilot comparative study in folliculitis decalvans. J. Eur. Acad. Dermatol. Venereol. 27, 853-860 (2013).
8. Puhvel, S. M., Reisner, R. M. & Amirian, D. A. Quantification of bacteria in isolated pilosebaceous follicles in normal skin. J. Invest. Dermatol. 65, 525-531 (1975).
9. Donaldson, G. P., Lee, S. M. & Mazmanian, S. K. Gut biogeography of the bacterial microbiota. Nat. Rev. Microbiol. 14, 20-32 (2016).
10. Peterson, L. W. & Artis, D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14, 141-153 (2014).
11. Albenberg, L. et al. Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology 147, 1055-1063.e8 (2014).
12. Lind Due, V., Bonde, J., Kann, T. & Perner, A. Extremely low oxygen tension in the rectal lumen of human subjects. Acta Anaesthesiol. Scand. 47, 372 (2003).
13. Crompton, D. W. T., Shrimpton, D. H. & Silver, I. A. Measurements of the oxygen tension in the lumen of the small intestine of the domestic duck. J. Exp. Biol. 43, 473-478 (1965).
14. Strauss, J. S., Pochi, P. E. & Downing, D. T. The sebaceous glands: twenty-five years of progress. J. Invest. Dermatol. 67, 90-97 (1976).
15. Nicolaides, N. Skin lipids: their biochemical uniqueness. Science 186, 19-26 (1974).
16. Drake, D. R., Brogden, K. A., Dawson, D. V. & Wertz, P. W. Thematic review series: skin lipids. Antimicrobial lipids at the skin surface. J. Lipid Res. 49, 4-11 (2008).
17. Puhvel, S. M., Reisner, R. M. & Sakamoto, M. Analysis of lipid composition of isolated human sebaceous gland homogenates after incubation with cutaneous bacteria. Thin-layer chromatography. J. Invest. Dermatol. 64, 406-411 (1975).
18. Sanford, J. A. et al. Inhibition of HDAC8 and HDAC9 by microbial short-chain fatty acids breaks immune tolerance of the epidermis to TLR ligands. Sci. Immunol. 1, eaah4609 (2016).
19. Scholz, C. F. P. & Kilian, M. The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. Int. J. Syst. Evol. Microbiol. 66, 4422-4432 (2016).
20. Grice, E. A. et al. Topographical and temporal diversity of the human skin microbiome. Science 324, 1190-1192 (2009).
21. Oh, J. et al. Biogeography and individuality shape function in the human skin metagenome. Nature 514, 59-64 (2014).
22. Byrd, A. L. et al. Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis. Sci. Transl. Med. 9, eaal4651 (2017).
23. Chu, D. M. et al. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat. Med. 23, 314-326 (2017).
24. Oh, J., Conlan, S., Polley, E. C., Segre, J. A. & Kong, H. H. Shifts in human skin and nares microbiota of healthy children and adults. Genome Med. 4, 77 (2012).
25. Oh, J., Byrd, A. L., Park, M., Kong, H. H. & Segre, J. A. Temporal stability of the human skin microbiome. Cell 165, 854-866 (2016).
26. Kong, H. H. et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 22, 850-859 (2012).
27. Otto, M. Staphylococcus epidermidis-the accidental pathogen. Nat. Rev. Microbiol. 7, 555-567 (2009).
28. Ramsey, M. M., Freire, M. O., Gabrilska, R. A., Rumbaugh, K. P. & Lemon, K. P. Staphylococcus aureus shifts toward commensalism in response to Corynebacterium species. Front. Microbiol. 7, 1230 (2016).
29. Naik, S. et al. Compartmentalized control of skin immunity by resident commensals. Science 337, 1115-1119 (2012).
30. Cebra, J. J. Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 69, 1046S-1051S (1999).
31. Chehoud, C. et al. Complement modulates the cutaneous microbiome and inflammatory milieu. Proc. Natl Acad. Sci. USA 110, 15061-15066 (2013).
32. Nagy, I. et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect. 8, 2195-2205 (2006).
33. Christensen, G. J. M. et al. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis. BMC Genomics 17, 152 (2016).
34. Cogen, A. L. et al. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J. Invest. Dermatol. 130, 192-200 (2010).
35. Nakatsuji, T. et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci. Transl. Med. 9, eaah4680 (2017).
36. Kllenius, G., Correia-Neves, M., Buteme, H., Hamasur, B. & Svenson, S. B. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations. Tuberculosis (Edinb.) 96, 120-130 (2016).
37. Afonso-Barroso, A. et al. Lipoarabinomannan mannose caps do not affect mycobacterial virulence or the induction of protective immunity in experimental animal models of infection and have minimal impact on in vitro inflammatory responses. Cell. Microbiol. 15, 660-674 (2013).
38. Briken, V., Porcelli, S. A., Besra, G. S. & Kremer, L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 53, 391-403 (2004).
39. Chatterjee, D. & Khoo, K.-H. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 8, 113-120 (1998).
40. Dao, D. N. et al. Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages. Infect. Immun. 72, 2067-2074 (2004).
41. Doz, E. et al. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. J. Biol. Chem. 282, 26014-26025 (2007).
42. Fukuda, T. et al. Critical roles for lipomannan and lipoarabinomannan in cell wall integrity of mycobacteria and pathogenesis of tuberculosis. MBio 4, e00472-e12 (2013).
43. Ishikawa, E., Mori, D. & Yamasaki, S. Recognition of mycobacterial lipids by immune receptors. Trends Immunol. 38, 66-76 (2017).
44. Bomar, L., Brugger, S. D., Yost, B. H., Davies, S. S. & Lemon, K. P. Corynebacterium accolens releases antipneumococcal free fatty acids from human nostril and skin surface triacylglycerols. MBio 7, e01725-e15 (2016).
45. Naik, S. et al. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature 520, 104-108 (2015).
46. Linehan, J. L. et al. Non-classical immunity controls microbiota impact on skin immunity and tissue repair. Cell (in the press).
47. Clark, R. A. et al. The vast majority of CLA+ T cells are resident in normal skin. J. Immunol. 176, 4431-4439 (2006).
48. Metze, D. et al. Immunohistochemical demonstration of immunoglobulin A in human sebaceous and sweat glands. J. Invest. Dermatol. 92, 13-17 (1989).
49. Okada, T., Konishi, H., Ito, M., Nagura, H. & Asai, J. Identification of secretory immunoglobulin A in human sweat and sweat glands. J. Invest. Dermatol. 90, 648-651 (1988).
50. Fagarasan, S. et al. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 298, 1424-1427 (2002).
51. Macpherson, A. J., Hunziker, L., McCoy, K. & Lamarre, A. IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes Infect. 3, 1021-1035 (2001).
52. Kawamoto, S. et al. The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut. Science 336, 485-489 (2012).
53. van der Waaij, L. A., Limburg, P. C., Mesander, G. & van der Waaij, D. In vivo IgA coating of anaerobic bacteria in human faeces. Gut 38, 348-354 (1996).
54. Shroff, K. E., Meslin, K. & Cebra, J. J. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect. Immun. 63, 3904-3913 (1995).
55. Macpherson, A. J. & Uhr, T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303, 1662-1665 (2004).
56. Vossenkmper, A. et al. A role for gut-associated lymphoid tissue in shaping the human B cell repertoire. J. Exp. Med. 210, 1665-1674 (2013).
57. ORiordan, K. & Lee, J. C. Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev. 17, 218-234 (2004).
58. Cheng, B. L. et al. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection. Hum. Vaccin. Immunother. 13, 1609-1614 (2017).
59. Zimmermann, M. & Fischbach, M. A. A family of pyrazinone natural products from a conserved nonribosomal peptide synthetase in Staphylococcus aureus. Chem. Biol. 17, 925-930 (2010).
60. Wyatt, M. A. et al. Staphylococcus aureus nonribosomal peptide secondary metabolites regulate virulence. Science 329, 294-296 (2010).
61. Scharschmidt, T. C. et al. A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes. Immunity 43, 1011-1021 (2015).
62. Scharschmidt, T. C. et al. Commensal microbes and hair follicle morphogenesis coordinately drive Treg migration into neonatal skin. Cell Host Microbe 21, 467-477.e5 (2017).
63. Lai, Y. et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat. Med. 15, 1377-1382 (2009).
64. Loesche, M. et al. Temporal stability in chronic wound microbiota is associated with poor healing. J. Invest. Dermatol. 137, 237-244 (2017).
65. Kalan, L. et al. Redefining the chronic-wound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing. MBio 7, e01058-e16 (2016).
66. Feingold, K. R. The outer frontier: the importance of lipid metabolism in the skin. J. Lipid Res. 50 (Suppl), S417-S422 (2009).
67. Brandner, J. M. Importance of tight junctions in relation to skin barrier function. Curr. Probl. Dermatol. 49, 27-37 (2016).
68. Natsuga, K. Epidermal barriers. Cold Spring Harb. Perspect. Med. 4, a018218 (2014).
69. McLean, W. H. I. Filaggrin failure-from ichthyosis vulgaris to atopic eczema and beyond. Br. J. Dermatol. 175 (Suppl 2), 4-7 (2016).
70. Madison, K. C. Barrier function of the skin: la raison dtre of the epidermis. J. Invest. Dermatol. 121, 231-241 (2003).
71. Cleaver, J. E. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum. J. Dermatol. Sci. 23, 1-11 (2000).
72. Martincorena, I. et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880-886 (2015).
73. Has, C. & Bruckner-Tuderman, L. The genetics of skin fragility. Annu. Rev. Genomics Hum. Genet. 15, 245-268 (2014).
74. Capell, B. C., Tlougan, B. E. & Orlow, S. J. From the rarest to the most common: insights from progeroid syndromes into skin cancer and aging. J. Invest. Dermatol. 129, 2340-2350 (2009).
75. Tott, J. E. et al. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br. J. Dermatol. 175, 687-695 (2016).
76. Tott, J. E. E. et al. A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea. Eur. J. Clin. Microbiol. Infect. Dis. 35, 1069-1077 (2016).
77. Huang, J. T., Abrams, M., Tlougan, B., Rademaker, A. & Paller, A. S. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 123, e808-e814 (2009).
78. Kobayashi, T. et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity 42, 756-766 (2015).
79. Leyden, J. J., Marples, R. R. & Kligman, A. M. Staphylococcus aureus in the lesions of atopic dermatitis. Br. J. Dermatol. 90, 525-530 (1974).
80. Conti, F. et al. Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus. Arthritis Res. Ther. 18, 177 (2016).
81. Nakagawa, S. et al. Staphylococcus aureus virulent PSMα peptides induce keratinocyte alarmin release to orchestrate IL-17-dependent skin inflammation. Cell Host Microbe 22, 667-677.e5 (2017).
82. Liu, H. et al. Staphylococcus aureus epicutaneous exposure drives skin inflammation via IL-36-mediated T cell responses. Cell Host Microbe 22, 653-666.e5 (2017).
83. Otto, M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu. Rev. Microbiol. 64, 143-162 (2010).
84. de Haas, C. J. C. et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J. Exp. Med. 199, 687-695 (2004).
85. Luong, T. T. & Lee, C. Y. Overproduction of type 8 capsular polysaccharide augments Staphylococcus aureus virulence. Infect. Immun. 70, 3389-3395 (2002).
86. Uhln, M. et al. Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J. Biol. Chem. 259, 1695-1702 (1984).
87. Palmqvist, N., Patti, J. M., Tarkowski, A. & Josefsson, E. Expression of staphylococcal clumping factor A impedes macrophage phagocytosis. Microbes Infect. 6, 188-195 (2004).
88. Peschel, A. et al. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274, 8405-8410 (1999).
89. Foster, T. J. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3, 948-958 (2005).
90. Rooijakkers, S. H. M. et al. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat. Immunol. 6, 920-927 (2005).
91. Sonesson, A. et al. Identification of bacterial biofilm and the Staphylococcus aureus derived protease, staphopain, on the skin surface of patients with atopic dermatitis. Sci. Rep. 7, 8689 (2017).
92. Zhang, L. J. et al. Innate immunity. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection. Science 347, 67-71 (2015).
93. Joshi, G. S., Spontak, J. S., Klapper, D. G. & Richardson, A. R. Arginine catabolic mobile element encoded speG abrogates the unique hypersensitivity of Staphylococcus aureus to exogenous polyamines. Mol. Microbiol. 82, 9-20 (2011).
94. Thurlow, L. R. et al. Functional modularity of the arginine catabolic mobile element contributes to the success of USA300 methicillin-resistant Staphylococcus aureus. Cell Host Microbe 13, 100-107 (2013).
95. Wentworth, A. B., Drage, L. A., Wengenack, N. L., Wilson, J. W. & Lohse, C. M. Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population-based study. Mayo Clin. Proc. 88, 38-45 (2013).
96. Merritt, R. W. et al. Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl. Trop. Dis. 4, e911 (2010).
97. Houben, R. M. G. J. & Dodd, P. J. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 13, e1002152 (2016).
98. World Health Organization. Global Tuberculosis Report 2016; http://apps.who. int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua= 1 (2016)
99. Haley, C. A. Treatment of latent tuberculosis infection. Microbiol. Spectr. 5, TNMI7-0039-2016 (2017).
100. Sehgal, V. N. Leprosy. Dermatol. Clin. 12, 629-644 (1994).
101. Talhari, C., Talhari, S. & Penna, G. O. Clinical aspects of leprosy. Clin. Dermatol. 33, 26-37 (2015).
102. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390, 1151-1210 (2017).
103. Wansbrough-Jones, M. & Phillips, R. Buruli ulcer: emerging from obscurity. Lancet 367, 1849-1858 (2006).
104. Marion, E. et al. Mycobacterial toxin induces analgesia in Buruli ulcer by targeting the angiotensin pathways. Cell 157, 1565-1576 (2014).
105. Kashem, S. W. et al. Nociceptive sensory fibers drive interleukin-23 production from CD301b+ dermal dendritic cells and drive protective cutaneous immunity. Immunity 43, 515-526 (2015).
106. Chiu, I. M. et al. Bacteria activate sensory neurons that modulate pain and inflammation. Nature 501, 52-57 (2013).
107. Cardoso, V. et al. Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. Nature 549, 277-281 (2017).
108. Bellono, N. W. et al. Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways. Cell 170, 185-198 (2017).
109. Fung, T. C. et al. Lymphoid tissue-resident commensal bacteria promote members of the IL-10 cytokine family to establish mutualism. Immunity 44, 634-646 (2016).
110. Sonnenberg, G. F. et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336, 1321-1325 (2012).
111. Davis, J. M. & Ramakrishnan, L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37-49 (2009).
112. Horsburgh, C. R. J., Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N. Engl. J. Med. 350, 2060-2067 (2004).
113. Adams, K. N. et al. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145, 39-53 (2011).
114. Schnappinger, D. et al. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198, 693-704 (2003).
115. Cunningham, A. F. & Spreadbury, C. L. Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton α -crystallin homolog. J. Bacteriol. 180, 801-808 (1998).
116. Rittershaus, E. S. C., Baek, S.-H. & Sassetti, C. M. The normalcy of dormancy: common themes in microbial quiescence. Cell Host Microbe 13, 643-651 (2013).
117. Bartek, I. L. et al. Mycobacterium tuberculosis Lsr2 is a global transcriptional regulator required for adaptation to changing oxygen levels and virulence. MBio 5, e01106-e01114 (2014).
118. Eoh, H. et al. Metabolic anticipation in Mycobacterium tuberculosis. Nat. Microbiol. 2, 201784 (2017).
119. Galagan, J. E. et al. The Mycobacterium tuberculosis regulatory network and hypoxia. Nature 499, 178-183 (2013).
120. Lin, P. L. et al. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat. Med. 20, 75-79 (2014).
121. Hannigan, G. D. et al. The human skin double-stranded DNA virome: topographical and temporal diversity, genetic enrichment, and dynamic associations with the host microbiome. MBio 6, e01578-e15 (2015).
122. Hickman, H. D. et al. Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin. Cell Host Microbe 13, 155-168 (2013).
123. Cush, S. S. et al. Locally produced IL-10 limits cutaneous vaccinia virus spread. PLoS Pathog. 12, e1005493 (2016).
124. Carbone, F. R. Tissue-resident memory T cells and fixed immune surveillance in nonlymphoid organs. J. Immunol. 195, 17-22 (2015).
125. Mueller, S. N., Gebhardt, T., Carbone, F. R. & Heath, W. R. Memory T cell subsets, migration patterns, and tissue residence. Annu. Rev. Immunol. 31, 137-161 (2013).
126. Lanas, A. & Chan, F. K. L. Peptic ulcer disease. Lancet 390, 613-624 (2017).
127. Kalisperati, P. et al. Inflammation, DNA damage, Helicobacter pylori and gastric tumorigenesis. Front. Genet. 8, 20 (2017).
128. Peek, R. M., Jr & Blaser, M. J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2, 28-37 (2002).
129. Kienesberger, S. et al. Gastric Helicobacter pylori infection affects local and distant microbial populations and host responses. Cell Reports 14, 1395-1407 (2016).
130. Lehman, H. Skin manifestations of primary immune deficiency. Clin. Rev. Allergy Immunol. 46, 112-119 (2014).
131. Barnard, E., Shi, B., Kang, D., Craft, N. & Li, H. The balance of metagenomic elements shapes the skin microbiome in acne and health. Sci. Rep. 6, 39491 (2016).
132. Agak, G. W. et al. Propionibacterium acnes Induces an IL-17 response in acne vulgaris that is regulated by vitamin A and vitamin D. J. Invest. Dermatol. 134, 366-373 (2014).
133. Fitz-Gibbon, S. et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J. Invest. Dermatol. 133, 2152-2160 (2013).
134. Ring, H. C. et al. The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls. JAMA Dermatol. 153, 897-905 (2017).
135. Wollenberg, M. S. et al. Propionibacterium-produced coproporphyrin III induces Staphylococcus aureus aggregation and biofilm formation. MBio 5, e01286-e14 (2014).
136. Shu, M. et al. Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus. PLoS One 8, e55380 (2013).
137. Barton, E. S. et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447, 326-329 (2007).
138. Yager, E. J. et al. γ -Herpesvirus-induced protection against bacterial infection is transient. Viral Immunol. 22, 67-72 (2009).
139. Perry, S. et al. Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One 5, e8804 (2010).
140. Arnold, I. C. et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J. Clin. Invest. 121, 3088-3093 (2011).
141. Cheung, G. Y. C. & Otto, M. Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children. Curr. Opin. Infect. Dis. 23, 208-216 (2010).
142. Rohlke, F. & Stollman, N. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap. Adv. Gastroenterol. 5, 403-420 (2012).
143. Panigrahi, P. et al. A randomized synbiotic trial to prevent sepsis among infants in rural India. Nature 548, 407-412 (2017).
144. Nakatsuji, T. et al. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating β -defensin-2 expression. J. Invest. Dermatol. 130, 985-994 (2010).
145. Falchook, G. S. et al. Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810. J. Immunother. Cancer 4, 70 (2016).
146. Morris, V. K. et al. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Lancet Oncol. 18, 446-453 (2017).
147. Mahoney, K. M., Freeman, G. J. & McDermott, D. F. The next immunecheckpoint inhibitors: PD-1/PD-L1 blockade in melanoma. Clin. Ther. 37, 764-782 (2015).
148. Cassler, N. M. & Brownell, I. PD-1 checkpoint blockade is an emerging treatment for Merkel cell carcinoma. Br. J. Dermatol. 176, 18 (2017).
149. Sivan, A. et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084-1089 (2015).
150. Vtizou, M. et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079-1084 (2015).
151. Golden, J. B. et al. Chronic, not acute, skin-specific inflammation promotes thrombosis in psoriasis murine models. J. Transl. Med. 13, 382 (2015).
152. Santilli, S. et al. Visualization of atherosclerosis as detected by coronary artery calcium and carotid intima-media thickness reveals significant atherosclerosis in a cross-sectional study of psoriasis patients in a tertiary care center. J. Transl. Med. 14, 217 (2016).
153. Wang, Y. et al. Chronic skin-specific inflammation promotes vascular inflammation and thrombosis. J. Invest. Dermatol. 132, 2067-2075 (2012).
154. Evensen, K. et al. Increased subclinical atherosclerosis in patients with chronic plaque psoriasis. Atherosclerosis 237, 499-503 (2014).
155. Tomura, M. et al. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J. Clin. Invest. 120, 883-893 (2010).
156. Tomura, M. et al. Tracking and quantification of dendritic cell migration and antigen trafficking between the skin and lymph nodes. Sci. Rep. 4, 6030 (2014).
157. Geherin, S. A. et al. The skin, a novel niche for recirculating B cells. J. Immunol. 188, 6027-6035 (2012).
158. Belkaid, Y. & Segre, J. A. Dialogue between skin microbiota and immunity. Science 346, 954-959 (2014).
159. Gallo, R. L. & Hooper, L. V. Epithelial antimicrobial defence of the skin and intestine. Nat. Rev. Immunol. 12, 503-516 (2012).
160. Nithya, S., Radhika, T. & Jeddy, N. Loricrin-an overview. J. Oral Maxillofac. Pathol. 19, 64-68 (2015).
161. Iguchi, A. et al. A complete view of the genetic diversity of the Escherichia coli O-antigen biosynthesis gene cluster. DNA Res. 22, 101-107 (2015).